PMC:7519301 / 478-906
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T1 | 80-87 | Body_part | denotes | genomes | http://purl.org/sig/ont/fma/fma84116 |
| T2 | 114-121 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T8 | 69-77 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T9 | 69-73 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T10 | 307-315 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T11 | 307-311 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T12 | 420-428 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T6 | 142-145 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
| T7 | 338-339 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T1 | 114-121 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id | tao:has_standard_notation |
|---|---|---|---|---|---|---|
| 10 | 108-113 | Gene | denotes | Spike | Gene:43740568 | |
| 11 | 227-231 | Gene | denotes | ACE2 | Gene:59272 | |
| 14 | 69-79 | Species | denotes | SARS-CoV-2 | Tax:2697049 | |
| 15 | 307-317 | Species | denotes | SARS-CoV-2 | Tax:2697049 | |
| 17 | 127-132 | Mutation | denotes | D614G | p.D614G | |
| 37 | 420-428 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T7 | 89-241 | Sentence | denotes | In the immunogenic Spike protein, the D614G mutation has become consensus, yet there is no evidence of mutations affecting binding to the ACE2 receptor. |
| T8 | 242-388 | Sentence | denotes | Our results suggest that, to date, the limited diversity seen in SARS-CoV-2 should not preclude a single vaccine from providing global protection. |
| T9 | 390-398 | Sentence | denotes | Abstract |